Landmark Wealth Management (New York)’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Landmark Wealth Management (New York)'s BMY Position: Q2 2026 in Review
Landmark Wealth Management (New York) held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 14,424 shares worth $831K. The position accounts for 0.2% of the portfolio, ranked #82.
Landmark Wealth Management (New York) first reported a position in BMY in Q1 2026 and has held it in 2 quarters since. The position peaked at $875K in Q1 2026. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Landmark Wealth Management (New York) held 14,424 shares of Bristol-Myers Squibb worth $831K as of Q2 2026.
- Landmark Wealth Management (New York) left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.2% of Landmark Wealth Management (New York)'s portfolio in Q2 2026, its #82 holding.
- Landmark Wealth Management (New York) first reported a position in Bristol-Myers Squibb in Q1 2026 and has held it in 2 quarters since.
- Landmark Wealth Management (New York)'s Bristol-Myers Squibb position peaked at $875K in Q1 2026.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Landmark Wealth Management (New York)'s 13F filing for Q2 2026, filed 10 Aug 2026.